Cargando…
Noninvasive Submental Fat Compartment Treatment
BACKGROUND: KYBELLA, ATX-101, is an injectable form of sodium deoxycholic acid. It is currently the only Food and Drug Administration–approved injectable drug for the reduction of submental fat. OBJECTIVES: A literature review and discussion of the treatment of submental fat. RESULTS: KYBELLA is a w...
Autor principal: | Shamban, Ava T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5172481/ https://www.ncbi.nlm.nih.gov/pubmed/28018773 http://dx.doi.org/10.1097/GOX.0000000000001155 |
Ejemplares similares
-
Technical Considerations for Filler and Neuromodulator Refinements
por: Montes, José Raúl, et al.
Publicado: (2016) -
Skincare Bootcamp: The Evolving Role of Skincare
por: Rodan, Katie, et al.
Publicado: (2016) -
Understanding How to Prevent and Treat Adverse Events of Fillers and Neuromodulators
por: Ablon, Glynis
Publicado: (2016) -
The Unique Value of Core-only Continuing Medical Education
por: Lupo, Mary P., et al.
Publicado: (2016) -
Review of 3-dimensional Facial Anatomy: Injecting Fillers and Neuromodulators
por: Sieber, David A., et al.
Publicado: (2016)